4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-26-000094
Options or other derivatives
- Principal Accounting Officer acquired 9,450 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Aneja Nikhil · Principal Accounting Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-09 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +9,450 | 9,450 | D |
Loading xslF345X05/form4.xml…